1.	Phase II Study of Intratumoral Fowlpox-TRICOM in Patients With Metastatic Melanoma Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UCCRC-12759A, NCI-6038, 6038, NCT00087373
2.	Phase I Pilot Study of Recombinant Fowlpox-TRICOM Vaccine in Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx or Nodal or Dermal Metastases Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: NCI-01-DC-0006, NCI-3210, NCT00021424
3.	Phase I Randomized Study of Intratumoral rF-B7.1 Vaccine Versus Recombinant Fowlpox-TRICOM Vaccine in Patients With Metastatic Solid Tumors Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CPMC-IRB-14535, AECM-01-122, NCI-3351, CPMC-IRB-01-122, NCT00030693, 3351